These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36935853)

  • 41. Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases.
    Cuccia F; Rigo M; Gurrera D; Nicosia L; Mazzola R; Figlia V; Giaj-Levra N; Ricchetti F; Attinà G; Pastorello E; De Simone A; Naccarato S; Sicignano G; Ruggieri R; Alongi F
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3269-3277. PubMed ID: 34268583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Using Unedited CT-Based DIR-Propagated Autocontours on Online ART for Pancreatic SBRT.
    Magallon-Baro A; Milder MTW; Granton PV; den Toom W; Nuyttens JJ; Hoogeman MS
    Front Oncol; 2022; 12():910792. PubMed ID: 35756687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dosimetric evaluation of magnetic resonance imaging-guided adaptive radiation therapy in pancreatic cancer by extent of re-contouring of organs-at-risk.
    Song JY; Chie EK; Kang SH; Jeon YJ; Ko YA; Kim DY; Kang HC
    Radiat Oncol J; 2022 Dec; 40(4):242-250. PubMed ID: 36606301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases.
    Al-Hallaq HA; Chmura SJ; Salama JK; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Robinson CG; Pisansky TM; Winter KA; White JR; Xiao Y; Matuszak MM
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):155-163. PubMed ID: 27843033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
    Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
    Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy.
    Mallory M; Pokhrel D; Badkul R; Jiang H; Lominska C; Wang F
    J Appl Clin Med Phys; 2018 Mar; 19(2):54-61. PubMed ID: 29349867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereotactic MR-guided adaptive radiation therapy for peripheral lung tumors.
    Finazzi T; Palacios MA; Haasbeek CJA; Admiraal MA; Spoelstra FOB; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
    Radiother Oncol; 2020 Mar; 144():46-52. PubMed ID: 31710943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of Daily Online Plan Adaptation Strategies for a Cohort of Pancreatic Cancer Patients Treated with SBRT.
    Magallon-Baro A; Milder MTW; Granton PV; Nuyttens JJ; Hoogeman MS
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):208-219. PubMed ID: 33811976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intra-fraction motion of pelvic oligometastases and feasibility of PTV margin reduction using MRI guided adaptive radiotherapy.
    Snyder J; Smith B; St-Aubin J; Dunkerley D; Shepard A; Caster J; Hyer D
    Front Oncol; 2023; 13():1098593. PubMed ID: 37152034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting personalised and progressive adaptive dose escalation to gross tumour volume using knowledge-based planning models for inoperable advanced-stage non-small cell lung cancer patients treated with volumetric modulated arc therapy.
    Tambe NS; Pires IM; Moore C; Wieczorek A; Upadhyay S; Beavis AW
    Biomed Phys Eng Express; 2022 Mar; 8(3):. PubMed ID: 35189613
    [No Abstract]   [Full Text] [Related]  

  • 51. Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases.
    Chi A; Liao Z; Nguyen NP; Xu J; Welsh JS; Jang SY; Howe C; Komaki R
    PLoS One; 2012; 7(4):e35809. PubMed ID: 22558228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stereotactic radiotherapy of intrapulmonary lesions: comparison of different dose calculation algorithms for Oncentra MasterPlan®.
    Troeller A; Garny S; Pachmann S; Kantz S; Gerum S; Manapov F; Ganswindt U; Belka C; Söhn M
    Radiat Oncol; 2015 Feb; 10():51. PubMed ID: 25888786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Critical structure sparing in stereotactic ablative radiotherapy for central lung lesions: helical tomotherapy vs. volumetric modulated arc therapy.
    Chi A; Ma P; Fu G; Hobbs G; Welsh JS; Nguyen NP; Jang SY; Dai J; Jin J; Komaki R
    PLoS One; 2013; 8(4):e59729. PubMed ID: 23577071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stereotactic Magnetic Resonance-Guided Daily Adaptive SABR (SMART) for Localised Non-Metastatic Pancreatic Cancer: First Reported Clinical Outcomes From the UK.
    Nugent K; Mukherjee S; Teoh S; George B; Martin A; Gaya A; Aznar-Garcia L; Chu K; Robinson M; Maughan T; Good J
    Clin Oncol (R Coll Radiol); 2024 Sep; 36(9):576-584. PubMed ID: 38902119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases.
    Ding S; Liu B; Zheng S; Wang D; Liu M; Liu H; Zhang P; Peng K; He H; Zhou R; Guo J; Qiu B; Huang X; Liu H
    Clin Transl Radiat Oncol; 2023 May; 40():100602. PubMed ID: 36910023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment.
    Winkel D; Bol GH; Werensteijn-Honingh AM; Intven MPW; Eppinga WSC; Hes J; Snoeren LMW; Sikkes GG; Gadellaa-van Hooijdonk CGM; Raaymakers BW; Jürgenliemk-Schulz IM; Kroon PS
    Radiother Oncol; 2020 May; 146():118-125. PubMed ID: 32146257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR).
    Kim M; Schiff JP; Price A; Laugeman E; Samson PP; Kim H; Badiyan SN; Henke LE
    Radiat Oncol; 2022 Sep; 17(1):157. PubMed ID: 36100866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
    Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
    Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT.
    de Chavez R; Grogan G; Hug B; Howe K; Grigg A; Waterhouse D; Lane J; Glyde A; Brown E; Bydder S; Pryor D; Hargrave C; Charles PH; Hellyer J; Ebert MA
    Med Dosim; 2022 Spring; 47(1):61-69. PubMed ID: 34551879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study.
    Willigenburg T; Beld E; Hes J; Lagendijk JJW; de Boer HCJ; Moerland MA; van der Voort van Zyp JRN
    Phys Imaging Radiat Oncol; 2020 Jul; 15():60-65. PubMed ID: 33458327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.